Cargando…

Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer

BACKGROUND: N6-methyladenosine-related long non-coding RNAs (m6A-related lncRNAs) are involved in the occurrence and progression of various cancers. However, it remains unclear whether m6A-related lncRNAs have potential roles in tumor immune microenvironment (TIME). METHODS: Herein, we investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Ziting, Zhang, Yitong, Chen, Ke, Yang, Xiujiang, Liu, Jianqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412838/ https://www.ncbi.nlm.nih.gov/pubmed/34511985 http://dx.doi.org/10.2147/IJGM.S327765

Ejemplares similares

Comprehensive analysis of the PD-L1 and immune infiltrates of N6-methyladenosine related long non-coding RNAs in bladder cancer
por: Xue, M. Q., et al.
Publicado: (2022)

N6-Methyladenosine Related Long Non-Coding RNAs and Immune Cell Infiltration in the Tumor Microenvironment of Gastric Cancer
por: Yu, Zhong lin, et al.
Publicado: (2021)

Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma
por: Yu, Zhong Lin, et al.
Publicado: (2021)

N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment
por: Shi, Yanlong, et al.
Publicado: (2023)

The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer
por: Lu, Senxu, et al.
Publicado: (2021)

Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer
por: Zuo, Luo, et al.
Publicado: (2021)

The Interaction Between N(6)-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers
por: Yao, Lin, et al.
Publicado: (2022)

The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer
por: Luo, Lin, et al.
Publicado: (2022)

N6-methyladenosine participates in mouse hippocampus neurodegeneration via PD-1/PD-L1 pathway
por: Hu, Wen, et al.
Publicado: (2023)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients
por: Wu, Wei Jun, et al.
Publicado: (2023)

Interplay Between N(6)-Methyladenosine (m(6)A) and Non-coding RNAs in Cell Development and Cancer
por: Fazi, Francesco, et al.
Publicado: (2019)

N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma
por: Yang, Kun, et al.
Publicado: (2022)

The Role of N6-Methyladenosine-Associated lncRNAs in the Immune Microenvironment and Prognosis of Colorectal Cancer
por: Yuan, Congfei, et al.
Publicado: (2022)

Links Between N (6)-Methyladenosine and Tumor Microenvironments in Colorectal Cancer
por: Zhang, Yundi, et al.
Publicado: (2022)

Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity
por: Xiong, Zhizhong, et al.
Publicado: (2021)

The emerging roles of N6-methyladenosine (m6A)-modified long non-coding RNAs in human cancers
por: Liu, Jingwen, et al.
Publicado: (2022)

Extensive translation of circular RNAs driven by N(6)-methyladenosine
por: Yang, Yun, et al.
Publicado: (2017)

Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer
por: Huang, Jianfeng, et al.
Publicado: (2022)

N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer
por: Lu, Miaolong, et al.
Publicado: (2021)

The Role of Critical N6-Methyladenosine-Related Long Non-Coding RNAs and Their Correlations with Immune Checkpoints in Renal Clear Cell Carcinoma
por: Deng, Wen, et al.
Publicado: (2021)

N(6)-methyladenosine is required for the hypoxic stabilization of specific mRNAs
por: Fry, Nate J., et al.
Publicado: (2017)

Positive natural selection of N6-methyladenosine on the RNAs of processed pseudogenes
por: Tan, Liqiang, et al.
Publicado: (2021)

Identification and characterization of N6‐methyladenosine modification of circRNAs in glioblastoma
por: Zhang, Yuhao, et al.
Publicado: (2021)

Analysis of N6-methyladenosine-modified mRNAs in diabetic cataract
por: Cai, Lei, et al.
Publicado: (2023)

Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer
por: Yu, Xinshuang, et al.
Publicado: (2021)

Comprehensive analysis of N(6)‐methyladenosine‐related long non‐coding RNAs for prognosis prediction in liver hepatocellular carcinoma
por: Zhu, Hong‐Xu, et al.
Publicado: (2021)

Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs
por: Zeng, Hanqian, et al.
Publicado: (2021)

Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer
por: Gu, Jing, et al.
Publicado: (2021)

Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma
por: Wang, Nengchao, et al.
Publicado: (2022)

The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs
por: Zhang, Lele, et al.
Publicado: (2020)

Research progress of N6-methyladenosine in colorectal cancer: A review
por: Lin, Yu, et al.
Publicado: (2023)

Integrated analysis on the N6‐methyladenosine‐related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma
por: Qiu, Yuqin, et al.
Publicado: (2021)

Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma
por: Zhao, Jianhui, et al.
Publicado: (2021)

Integrated Analyses Reveal Potential Functional N6-Methyladenosine-Related Long Noncoding RNAs in Adrenocortical Adenocarcinoma
por: Ding, Yafei, et al.
Publicado: (2022)

The dual role of N6‐methyladenosine modification of RNAs is involved in human cancers
por: He, Liujia, et al.
Publicado: (2018)

N (6)-methyladenosine enhances post-transcriptional gene regulation by microRNAs
por: Kanoria, Shaveta, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer
por: Ma, Mingyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_457u2ui53uq3golvaqqeijhofs